[{"Assets_0_FY_USD":771598000.0,"EarningsPerShareBasic_4_FY_USD":-3.4,"EarningsPerShareDiluted_4_FY_USD":-3.4,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":3322000.0,"NetIncomeLossConverted_4_FY_USD":-42793000.0,"RevenuesConverted_4_FY_USD":216136000.0,"StockholdersEquity_0_FY_USD":333890000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":12596000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":12596000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20220315"}]